Zobrazeno 1 - 10
of 136
pro vyhledávání: '"A. Lopez-Anaya"'
Autor:
Reiter, Lawrence A., Rizzi, James P., Pandit, Jayvardan, Lasut, Michael J., McGahee, Shunda M., Parikh, Vinod D., Blake, James F., Danley, Dennis E., Laird, Ellen R., Lopez-Anaya, Arturo, Lopresti-Morrow, Lori L., Mansour, Mahmoud N., Martinelli, Gary J., Mitchell, Peter G., Owens, Brian S., Pauly, Thomas A., Reeves, Lisa M., Schulte, Gayle K., Yocum, Sue A.
Publikováno v:
In Bioorganic & Medicinal Chemistry Letters 1999 9(2):127-132
Autor:
Sukhmani K. Padda, Laveena Chhatwani, Charlotte Jacobs, Lisa Zhou, Heather A. Wakelee, Arturo Lopez-Anaya
Publikováno v:
Anti-Cancer Drugs. 24:731-735
Gefitinib (an epidermal growth factor receptor tyrosine kinase inhibitor) and bexarotene (a rexinoid) affect similar oncogenic pathways and are both metabolized through cytochrome P450 CYP3A4. We studied the combination of bexarotene and gefitinib in
Autor:
Arturo Lopez-Anaya, Petr Zatloukal, Charlotte Jacobs, Gary Middleton, Heather A. Wakelee, Desiree Hao, D. Dunlop, Natasha B. Leighl, Rodryg Ramlau
Publikováno v:
Cancer Chemotherapy and Pharmacology. 69:815-824
This is a phase I study of the retinoid X receptor agonist bexarotene (Targretin(®)) in combination with the chemotherapeutic drugs cisplatin and vinorelbine and lipid-lowering therapy. This study looked for pharmacokinetic (PK) interactions between
Autor:
Eric K. Rowinsky, Chris H. Takimoto, Charlotte Jacobs, Arturo Lopez-Anaya, Quincy Chu, Heather A. Wakelee, J. Rodon
Publikováno v:
Cancer Chemotherapy and Pharmacology. 69:825-834
Preclinical data suggest that the synthetic retinoid bexarotene may be an effective chemopreventive agent and that it may act synergistically in combination with platinum-based chemotherapy. The primary objective of this study was to determine whethe
Autor:
Marja Mergui-Roelvink, Margarita Lymboura, Arturo Lopez-Anaya, A. C. Dubbelman, Jan H.M. Schellens, Alwin D. R. Huitema, Jos H. Beijnen, Larisa Reyderman, Barbara Koetz, Hilde Rosing, Robert S. Jansen
Publikováno v:
Drug Metabolism and Disposition. 40:313-321
This mass balance study investigated the metabolism and excretion of eribulin, a nontaxane microtubule dynamics inhibitor with a novel mechanism of action, in patients with advanced solid tumors. A single approximately 2 mg (approximately 80 μCi) do
Publikováno v:
Revista de Sanidad Militar. mar-abr1998, Vol. 52 Issue 2, p40. 5p. 2 Charts, 3 Graphs.
Autor:
Santo R. Cortina, R. J. Griffiths, Marcie L. Vaughn-Bowser, Arturo Lopez-Anaya, Lori L. Lopresti-Morrow, Kim F. McClure, Kathleen M. Donahue, Shunda M. McGahee, Mary E. Lame, Christopher S. Jones, James D. Eskra, Ralph P. Robinson, Ivan G. Otterness, Jennifer L. Liras, Matthew R. Reese, Lisa M. Tobiassen, Sue A. Yocum, Gary J. Martinelli, Peter G. Mitchell, Lawrence A. Reiter, Marcia L. Bliven
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 14:3389-3395
The SAR of a series of sterically hindered sulfonamide hydroxamic acids with relatively large P1' groups is described. The compounds typically spare MMP-1 while being potent inhibitors of MMP-13. The metabolically more stable compounds in the series
Publikováno v:
Journal of Liquid Chromatography & Related Technologies. 19:1277-1289
A sensitive, reproducible and rapid HPLC assay was developed for preformulation and stability studies of a potential radioprotector, S-2-(3-methylaminopropylamino) ethyl-phosphorothioate, WR-3689. This method is based on the elution of WR3689 by high
Publikováno v:
Scopus-Elsevier
Sustained release biodegradable microcapsules of AZT were prepared using different concentrations of copolymer of poly(lactic/glycolic) acid (PLGA 50:50 and PLGA 90:10). Solid microcapsules were collected following the complete evaporation of the sol
Publikováno v:
Biological Trace Element Research. 40:161-176
The effect of nutritional copper (Cu) deficiency on the antiinflammatory activity and pharmacokinetics of aspirin (ASA) was investigated in rats. Male, weanling Sprague-Dawley rats were fed either a Cu-deficient (CuD) or Cu-sufficient (CuS) diet for